FigureĀ 2.
Comparison of MR4.5 and EMR between the nilotinib arm and the dasatinib arm. Cumulative achievement rates of MR4.5 (A) and achievement rates of EMR (B). The results were calculated on the ITT population by means of the Cochran-Mantel-Haenszel (CMH) test.